Functional Roles of Fatty Acids and Their Effects on Human Health.

A variety of fatty acids exists in the diet of humans, in the bloodstream of humans, and in cells and tissues of humans. Fatty acids are energy sources and membrane constituents. They have biological activities that act to influence cell and tissue metabolism, function, and responsiveness to hormonal and other signals. The biological activities may be grouped as regulation of membrane structure and function; regulation of intracellular signaling pathways, transcription factor activity, and gene expression; and regulation of the production of bioactive lipid mediators. Through these effects, fatty acids influence health, well-being, and disease risk. The effects of saturated, cis monounsaturated, ω-6 and ω-3 polyunsaturated, and trans fatty acids are discussed. Although traditionally most interest in the health impact of fatty acids related to cardiovascular disease, it is now clear that fatty acids influence a range of other diseases, including metabolic diseases such as type 2 diabetes, inflammatory diseases, and cancer. Scientists, regulators, and communicators have described the biological effects and the health impacts of fatty acids according to fatty acid class. However, it is now obvious that within any fatty acid class, different members have different actions and effects. Thus, it would seem more appropriate to describe biological effects and health impacts of individual named fatty acids, although it is recognized that this would be a challenge when communicating outside of an academic environment (eg, to consumers).

[1]  N. Flamand,et al.  Regulation of inflammation by cannabinoids, the endocannabinoids 2‐arachidonoyl‐glycerol and arachidonoyl‐ethanolamide, and their metabolites , 2015, Journal of leukocyte biology.

[2]  E. Voest,et al.  Increased Plasma Levels of Chemoresistance-Inducing Fatty Acid 16:4(n-3) After Consumption of Fish and Fish Oil. , 2015, JAMA oncology.

[3]  P. Calder Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. , 2015, Biochimica et biophysica acta.

[4]  P. Calder,et al.  n-3 Long-chain PUFAs reduce respiratory morbidity caused by iron supplementation in iron-deficient South African schoolchildren: a randomized, double-blind, placebo-controlled intervention. , 2015, The American journal of clinical nutrition.

[5]  J. Chardigny,et al.  Is there a linear relationship between the dose of ruminant trans-fatty acids and cardiovascular risk markers in healthy subjects: results from a systematic review and meta-regression of randomised clinical trials , 2014, British Journal of Nutrition.

[6]  P. Calder Very long chain omega‐3 (n‐3) fatty acids and human health , 2014 .

[7]  L. Schwingshackl,et al.  Monounsaturated fatty acids, olive oil and health status: a systematic review and meta-analysis of cohort studies , 2014, Lipids in Health and Disease.

[8]  Albert Koulman,et al.  Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study , 2014, The lancet. Diabetes & endocrinology.

[9]  D. Mozaffarian,et al.  Plasma Phospholipid Trans‐Fatty Acids Levels, Cardiovascular Diseases, and Total Mortality: The Cardiovascular Health Study , 2014, Journal of the American Heart Association.

[10]  J. Dai,et al.  Effects of Omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: a meta-analysis of randomized controlled trials. , 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[11]  Simon G Thompson,et al.  Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. , 2014, Annals of internal medicine.

[12]  D. Alexander,et al.  Long-Chain Omega-3 Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid and Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2014, American journal of hypertension.

[13]  R. Sandhoff,et al.  Ceramide synthesis in the epidermis. , 2014, Biochimica et biophysica acta.

[14]  P. Calder,et al.  Omega-6 and omega-3 polyunsaturated fatty acids and allergic diseases in infancy and childhood. , 2014, Current pharmaceutical design.

[15]  Ann-Hwee Lee,et al.  Transcriptional Control of Hepatic Lipid Metabolism by SREBP and ChREBP , 2013, Seminars in Liver Disease.

[16]  G. Corrao,et al.  Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected]. , 2013, Atherosclerosis Supplements.

[17]  N. Parekh,et al.  Dietary fat in breast cancer survival. , 2013, Annual review of nutrition.

[18]  F. Velotti,et al.  Dietary ω-3 Polyunsaturated Fatty Acid DHA: A Potential Adjuvant in the Treatment of Cancer , 2013, BioMed research international.

[19]  M. Roncaglioni,et al.  n-3 fatty acids in patients with multiple cardiovascular risk factors. , 2013, The New England journal of medicine.

[20]  Xiao-ying Li,et al.  Short-term effects of fish-oil supplementation on heart rate variability in humans: a meta-analysis of randomized controlled trials. , 2013, The American journal of clinical nutrition.

[21]  C. Peterson,et al.  Omega-3 Fatty Acids Reduce Adipose Tissue Macrophages in Human Subjects With Insulin Resistance , 2013, Diabetes.

[22]  Dolores Corella,et al.  Primary prevention of cardiovascular disease with a Mediterranean diet. , 2013, The New England journal of medicine.

[23]  P. Lewandowski,et al.  Marine polyunsaturated fatty acids and cancer therapy , 2013, British Journal of Cancer.

[24]  An Pan,et al.  α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. , 2012, The American journal of clinical nutrition.

[25]  M. Krebs,et al.  Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. , 2012, The American journal of clinical nutrition.

[26]  V. Perkovic,et al.  Omega 3 Fatty Acids and Cardiovascular Outcomes: Systematic Review and Meta-Analysis , 2012, Circulation. Cardiovascular quality and outcomes.

[27]  E. Ntzani,et al.  Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. , 2012, JAMA.

[28]  S. Yusuf,et al.  n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. , 2012, The New England journal of medicine.

[29]  E. Riboli,et al.  Plasma Phospholipid Fatty Acid Concentration and Incident Coronary Heart Disease in Men and Women: The EPIC-Norfolk Prospective Study , 2012, PLoS medicine.

[30]  Huan Wang,et al.  Palmitoleate Induces Hepatic Steatosis but Suppresses Liver Inflammatory Response in Mice , 2012, PloS one.

[31]  P. Calder,et al.  Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis , 2012, British Journal of Nutrition.

[32]  H. Perera,et al.  Combined ω3 and ω6 Supplementation in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Refractory to Methylphenidate Treatment , 2012, Journal of child neurology.

[33]  M. Gerber Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies , 2012, British Journal of Nutrition.

[34]  H. Seo,et al.  Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. , 2012, Archives of internal medicine.

[35]  W. Harris,et al.  Fish oil -- how does it reduce plasma triglycerides? , 2012, Biochimica et biophysica acta.

[36]  J. Buckley,et al.  Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial. , 2012, Nutrition.

[37]  C. Ulrich,et al.  Fatigue, inflammation, and ω-3 and ω-6 fatty acid intake among breast cancer survivors. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  T. Kadowaki,et al.  Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation. , 2012, Cell metabolism.

[39]  M. Koshiba,et al.  Effects of Large Doses of Arachidonic Acid Added to Docosahexaenoic Acid on Social Impairment in Individuals With Autism Spectrum Disorders: A Double-Blind, Placebo-Controlled, Randomized Trial , 2012, Journal of clinical psychopharmacology.

[40]  P. Calder Mechanisms of action of (n-3) fatty acids. , 2012, The Journal of nutrition.

[41]  E. Smit,et al.  Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT , 2012, European Journal of Clinical Nutrition.

[42]  K. Clément,et al.  Dietary factors and low-grade inflammation in relation to overweight and obesity , 2011, British Journal of Nutrition.

[43]  R. Medema,et al.  Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. , 2011, Cancer cell.

[44]  T. Reiman,et al.  Supplementation with fish oil increases first‐line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer , 2011, Cancer.

[45]  M. Ferguson,et al.  Lean body mass gain in patients with head and neck squamous cell cancer treated perioperatively with a protein‐ and energy‐dense nutritional supplement containing eicosapentaenoic acid , 2011, Head and Neck.

[46]  K. Swedberg n-3 Fatty acids in cardiovascular disease. , 2011, The New England journal of medicine.

[47]  Christine M. Williams,et al.  Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome—LIPGENE: a European randomized dietary intervention study , 2011, International Journal of Obesity.

[48]  J. Hibbeln,et al.  Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. , 2011, The American journal of clinical nutrition.

[49]  T. Reiman,et al.  Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy , 2011, Cancer.

[50]  S. López,et al.  Oleic acid in olive oil: from a metabolic framework toward a clinical perspective. , 2011, Current pharmaceutical design.

[51]  P. Pérez-Martínez,et al.  Mediterranean diet rich in olive oil and obesity, metabolic syndrome and diabetes mellitus. , 2011, Current pharmaceutical design.

[52]  K. Wittkowski,et al.  Algal docosahexaenoic acid affects plasma lipoprotein particle size distribution in overweight and obese adults. , 2011, The Journal of nutrition.

[53]  P. Toth GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects , 2011 .

[54]  M. Garg,et al.  Docosapentaenoic acid (22:5n-3): a review of its biological effects. , 2011, Progress in lipid research.

[55]  John M. Davis,et al.  n-6 Fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials , 2010, British Journal of Nutrition.

[56]  P. Galan,et al.  Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial , 2010, BMJ : British Medical Journal.

[57]  G. Steinbeck,et al.  OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction , 2010, Circulation.

[58]  J. Geleijnse,et al.  n-3 fatty acids and cardiovascular events after myocardial infarction. , 2010, The New England journal of medicine.

[59]  Kai Simons,et al.  Revitalizing membrane rafts: new tools and insights , 2010, Nature Reviews Molecular Cell Biology.

[60]  B. Strandvik,et al.  EPA supplementation improves teacher rated behaviour and oppositional symptoms in children with ADHD Short title : RCT of EPA in ADHD , 2011 .

[61]  P. Calder,et al.  Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. , 2010, Atherosclerosis.

[62]  A. Zampelas Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. , 2010, Atherosclerosis.

[63]  M. Chatfield,et al.  Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial1234 , 2010, The American journal of clinical nutrition.

[64]  P. Calder,et al.  Cardiovascular effects of marine omega-3 fatty acids , 2010, The Lancet.

[65]  P. Calder,et al.  The effect of three lipid emulsions differing in fatty acid composition on growth, apoptosis and cell cycle arrest in the HT-29 colorectal cancer cell line. , 2010, Clinical nutrition.

[66]  S. Czernichow,et al.  n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations , 2010, British Journal of Nutrition.

[67]  B. Baune,et al.  Review: Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis , 2010, Therapeutic advances in endocrinology and metabolism.

[68]  J. Ntambi,et al.  Genetic control of de novo lipogenesis: role in diet-induced obesity , 2010, Critical reviews in biochemistry and molecular biology.

[69]  P. Kogner,et al.  Omega-3 fatty acids in cancer, the protectors of good and the killers of evil? , 2010, Experimental cell research.

[70]  D. Mozaffarian,et al.  Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2010, PLoS medicine.

[71]  R. DuBois,et al.  Eicosanoids and cancer , 2010, Nature Reviews Cancer.

[72]  F. Hu,et al.  Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. , 2010, The American journal of clinical nutrition.

[73]  F. Schick,et al.  Circulating Palmitoleate Strongly and Independently Predicts Insulin Sensitivity in Humans , 2009, Diabetes Care.

[74]  N. Samani,et al.  Saturated Fatty Acids Do Not Directly Stimulate Toll-Like Receptor Signaling , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[75]  F. Kim,et al.  Activation of NF-&kgr;B by Palmitate in Endothelial Cells: A Key Role for NADPH Oxidase-Derived Superoxide in Response to TLR4 Activation , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[76]  A. Choi,et al.  Fatty Acids Modulate Toll-like Receptor 4 Activation through Regulation of Receptor Dimerization and Recruitment into Lipid Rafts in a Reactive Oxygen Species-dependent Manner* , 2009, The Journal of Biological Chemistry.

[77]  S. Egert,et al.  Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. , 2009, The Journal of nutrition.

[78]  W. Willett,et al.  Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. , 2009, The American journal of clinical nutrition.

[79]  P. Calder,et al.  Fish oil n-3 polyunsaturated fatty acids selectively affect plasma cytokines and decrease illness in Thai schoolchildren: a randomized, double-blind, placebo-controlled intervention trial. , 2009, The Journal of pediatrics.

[80]  E. Levy,et al.  Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study. , 2009, Paediatrics & child health.

[81]  A. Verhoeven,et al.  Activation of Hepatic Lipase Expression by Oleic Acid: Possible Involvement of USF1 , 2009, Nutrients.

[82]  Walter C Willett,et al.  Dietary fats and prevention of type 2 diabetes. , 2009, Progress in lipid research.

[83]  M. Dorgan,et al.  Effect of fish oil on arrhythmias and mortality: systematic review , 2008, BMJ : British Medical Journal.

[84]  Gissi-Hf Investigators Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.

[85]  S. Watkins,et al.  Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism , 2008, Cell.

[86]  N. Meguid,et al.  Role of polyunsaturated fatty acids in the management of Egyptian children with autism. , 2008, Clinical biochemistry.

[87]  D. Jump N-3 polyunsaturated fatty acid regulation of hepatic gene transcription , 2008, Current opinion in lipidology.

[88]  S. Basu,et al.  Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic inflammation : longitudinal analyses in middle-aged men , 2008, British Journal of Nutrition.

[89]  U. Risérus Fatty acids and insulin sensitivity , 2008, Current opinion in clinical nutrition and metabolic care.

[90]  W. Harris,et al.  Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. , 2008, Atherosclerosis.

[91]  L. Tavazzi,et al.  ect of n-3 polyunsaturated fatty acids in patients with chronic heart failure ( the GISSI-HF trial ) : a randomised , double-blind , placebo-controlled trial , 1980 .

[92]  L. Cerchietti,et al.  Effects of Eicosapentaenoic and Docosahexaenoic n-3 Fatty Acids From Fish Oil and Preferential Cox-2 Inhibition on Systemic Syndromes in Patients With Advanced Lung Cancer , 2007, Nutrition and cancer.

[93]  C. Albert,et al.  Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. , 2007, Circulation.

[94]  P. Sorgi,et al.  Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder , 2007, Nutrition journal.

[95]  Y. Matsuzawa,et al.  Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis , 2007, The Lancet.

[96]  M. Guarcello,et al.  EPA-enriched oral nutritional support in patients with lung cancer: effects on nutritional status and quality of life , 2007 .

[97]  A. Farmer,et al.  Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes , 2007, Diabetologia.

[98]  J. Lau,et al.  Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. , 2006, Atherosclerosis.

[99]  G. Murray,et al.  Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[100]  R. Mensink,et al.  Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. , 2006, The American journal of clinical nutrition.

[101]  Ethan M Balk,et al.  n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. , 2006, The American journal of clinical nutrition.

[102]  P. Calder,et al.  Dietary α-linolenic acid and health-related outcomes: a metabolic perspective , 2006, Nutrition Research Reviews.

[103]  R. Deckelbaum,et al.  n-3 fatty acids and gene expression. , 2006, The American journal of clinical nutrition.

[104]  R. Deschenes,et al.  Thematic review series: Lipid Posttranslational Modifications. Protein palmitoylation by a family of DHHC protein S-acyltransferases Published, JLR Papers in Press, April 1, 2006. , 2006, Journal of Lipid Research.

[105]  L. Arterburn,et al.  Distribution, interconversion, and dose response of n-3 fatty acids in humans. , 2006, The American journal of clinical nutrition.

[106]  S. Bandinelli,et al.  Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. , 2006, The Journal of clinical endocrinology and metabolism.

[107]  T. Kuczek,et al.  EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors , 2003, Lipids.

[108]  W. Harris n-3 fatty acids and lipoproteins: Comparison of results from human and animal studies , 1996, Lipids.

[109]  B. Holub,et al.  Effect of dietary α-linolenic acid and its ratio to linoleic acid on platelet and plasma fatty acids and thrombogenesis , 1993, Lipids.

[110]  M. Elia,et al.  Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. , 2006, International journal of oncology.

[111]  J. Drai,et al.  Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. , 2005, The American journal of clinical nutrition.

[112]  M. Briel,et al.  Effect of different antilipidemic agents and diets on mortality: a systematic review. , 2005, Archives of internal medicine.

[113]  Nader Rifai,et al.  Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. , 2005, The Journal of nutrition.

[114]  Christoph Handschin,et al.  Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP , 2005, Cell.

[115]  P. Kris-Etherton,et al.  Dietary α-Linolenic Acid Reduces Inflammatory and Lipid Cardiovascular Risk Factors in Hypercholesterolemic Men and Women , 2004 .

[116]  P. Calder,et al.  Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans. , 2004, The American journal of clinical nutrition.

[117]  Hee-Yong Kim,et al.  Reduced G Protein-coupled Signaling Efficiency in Retinal Rod Outer Segments in Response to n-3 Fatty Acid Deficiency* , 2004, Journal of Biological Chemistry.

[118]  P. Calder n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. , 2004, Clinical science.

[119]  D. Baer,et al.  Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. , 2004, The American journal of clinical nutrition.

[120]  S. Clarke,et al.  Polyunsaturated fatty acids and gene expression , 2004, Current opinion in clinical nutrition and metabolic care.

[121]  J. Lau,et al.  Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease. , 2004, Evidence report/technology assessment.

[122]  S. Clarke The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors , 2004, Current opinion in lipidology.

[123]  P. Kris-Etherton,et al.  Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. , 2004, The Journal of nutrition.

[124]  Shih-Yi Huang,et al.  Omega-3 fatty acids in major depressive disorder A preliminary double-blind, placebo-controlled trial , 2003, European Neuropsychopharmacology.

[125]  E. Rimm,et al.  Habitual Dietary Intake of n-3 and n-6 Fatty Acids in Relation to Inflammatory Markers Among US Men and Women , 2003, Circulation.

[126]  J. Pankow,et al.  Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. , 2003, The American journal of clinical nutrition.

[127]  R. Mensink,et al.  Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. , 2003, The American journal of clinical nutrition.

[128]  J. Fernández-Real,et al.  Insulin resistance, inflammation, and serum fatty acid composition. , 2003, Diabetes care.

[129]  M. Garg,et al.  Human Nutrition and Metabolism Research Communication Macadamia Nut Consumption Lowers Plasma Total and LDL Cholesterol Levels in Hypercholesterolemic Men , 2003 .

[130]  P. Calder,et al.  Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. , 2003, The American journal of clinical nutrition.

[131]  P. Calder,et al.  Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial , 2003, The Lancet.

[132]  N. Espat,et al.  NF-kappa B inhibition by omega -3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[133]  G. Watts,et al.  Docosahexaenoic acid but not eicosapentaenoic acid increases LDL particle size in treated hypertensive type 2 diabetic patients. , 2003, Diabetes care.

[134]  Lawrence J Appel,et al.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2003, Circulation.

[135]  G. Watts,et al.  Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. , 2002, The American journal of clinical nutrition.

[136]  H. Arnesen,et al.  Serum non-esterified very long-chain PUFA are associated with markers of endothelial dysfunction. , 2002, Atherosclerosis.

[137]  D. Horrobin,et al.  A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. , 2002, Archives of general psychiatry.

[138]  D. Grobbee,et al.  Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials , 2002, Journal of hypertension.

[139]  P. Yaqoob Monounsaturated fatty acids and immune function , 2002, European Journal of Clinical Nutrition.

[140]  B. Chung,et al.  Oleic, linoleic and linolenic acids enhance receptor-mediated uptake of low density lipoproteins in Hep-G2 cells. , 2002, The Journal of nutritional biochemistry.

[141]  M. Santini,et al.  Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione , 2002, Circulation.

[142]  D. Jump,et al.  Dietary polyunsaturated fatty acids and regulation of gene transcription , 2002, Current opinion in lipidology.

[143]  C. Schindler,et al.  N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. , 2002, The American journal of medicine.

[144]  R. Belmaker,et al.  Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. , 2002, The American journal of psychiatry.

[145]  B. Puri,et al.  A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[146]  J. Bousquet,et al.  Endogenous anti-inflammatory mediators from arachidonate in human neutrophils. , 2002, Biochemical and biophysical research communications.

[147]  T. Hamazaki,et al.  The Effect of Docosahexaenoic Acid on Aggression in Elderly Thai Subjects—a Placebo-controlled Double-blind Study , 2002, Nutritional neuroscience.

[148]  A. Leaf,et al.  The Modulation of Ionic Currents in Excitable Tissues by n-3 Polyunsaturated Fatty Acids , 2001, The Journal of Membrane Biology.

[149]  F. Dickerson,et al.  A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. , 2001, The American journal of psychiatry.

[150]  P. Calder,et al.  Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. , 2001, The Journal of nutrition.

[151]  S. Rhee,et al.  Saturated Fatty Acids, but Not Unsaturated Fatty Acids, Induce the Expression of Cyclooxygenase-2 Mediated through Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[152]  G. Vankar,et al.  Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia , 2001, Schizophrenia Research.

[153]  B. M. Rasmussen,et al.  Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study , 2001, Diabetologia.

[154]  G. Watts,et al.  Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. , 2000, The American journal of clinical nutrition.

[155]  R. Abbott,et al.  Serum lipid effects of a high-monounsaturated fat diet based on macadamia nuts. , 2000, Archives of internal medicine.

[156]  Calder,et al.  Encapsulated fish oil enriched in α‐tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions , 2000, European journal of clinical investigation.

[157]  K. Nagao,et al.  Superiority of Dietary Safflower Oil over Olive Oil in Lowering Serum Cholesterol and Increasing Hepatic mRNAs for the LDL Receptor and Cholesterol 7α-Hydroxylase in Exogenously Hypercholesterolemic (ExHC) Rats , 2000, Bioscience, biotechnology, and biochemistry.

[158]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[159]  A. Stoll,et al.  Omega 3 Fatty Acids in Bipolar Disorder A Preliminary Double-blind, Placebo-Controlled Trial , 1999 .

[160]  S. Clarke,et al.  Regulation of gene expression by dietary fat. , 1999, Annual review of nutrition.

[161]  W. Wahli,et al.  Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. , 1997, Molecular endocrinology.

[162]  W. Harris,et al.  n-3 fatty acids and serum lipoproteins: human studies. , 1997, The American journal of clinical nutrition.

[163]  P. Baeuerle,et al.  Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. , 1996, Biochemical and biophysical research communications.

[164]  M. Mattson,et al.  Linoleic acid activates nuclear transcription factor-kappa B (NF-kappa B) and induces NF-kappa B-dependent transcription in cultured endothelial cells. , 1996, The American journal of clinical nutrition.

[165]  T. Hamazaki,et al.  The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. , 1996, The Journal of clinical investigation.

[166]  E. Mantzioris,et al.  The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. , 1996, The American journal of clinical nutrition.

[167]  R. Mensink,et al.  Dietary trans fatty acids and lipoprotein cholesterol. , 1995, The American journal of clinical nutrition.

[168]  P. Nestel,et al.  Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. , 1995, Journal of lipid research.

[169]  R W Byard,et al.  Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. , 1994, The American journal of clinical nutrition.

[170]  R. Byard,et al.  Fattyacidcompositionofbrain,retina, and erythrocytes in , 1994 .

[171]  J. Gordon,et al.  Genetic and biochemical studies of protein N-myristoylation. , 1994, Annual review of biochemistry.

[172]  F. Sacks,et al.  Does Fish Oil Lower Blood Pressure? A Meta‐Analysis of Controlled Trials , 1993, Circulation.

[173]  P. Whelton,et al.  Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. , 1993, Archives of internal medicine.

[174]  J. Besson,et al.  Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects. , 1993, Brain : a journal of neurology.

[175]  J. Manson,et al.  Intake of trans fatty acids and risk of coronary heart disease among women , 1993, The Lancet.

[176]  R. Mensink,et al.  Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[177]  J. Gustafsson,et al.  Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[178]  F. Ursini,et al.  Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[179]  W. Powell,et al.  Formation of monohydroxy derivatives of arachidonic acid, linoleic acid, and oleic acid during oxidation of low density lipoprotein by copper ions and endothelial cells. , 1992, Journal of lipid research.

[180]  P. Elwood,et al.  EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART) , 1989, The Lancet.

[181]  C. von Schacky,et al.  Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. , 1985, The Journal of clinical investigation.

[182]  M. Crawford,et al.  The long chain metabolites of linoleic avid linolenic acids in liver and brain in herbivores and carnivores. , 1976, Comparative biochemistry and physiology. B, Comparative biochemistry.

[183]  R. Wells,et al.  A preliminary investigation into the oxygen-combining properties of pogonophore haemoglobin. , 1976, Comparative biochemistry and physiology. A, Comparative physiology.